__timestamp | Bristol-Myers Squibb Company | Telix Pharmaceuticals Limited |
---|---|---|
Wednesday, January 1, 2014 | 15879000000 | 28336824 |
Thursday, January 1, 2015 | 16560000000 | 32319194 |
Friday, January 1, 2016 | 19427000000 | 29404631 |
Sunday, January 1, 2017 | 20776000000 | 31769230 |
Monday, January 1, 2018 | 22561000000 | 20439380 |
Tuesday, January 1, 2019 | 26145000000 | 24186536 |
Wednesday, January 1, 2020 | 42518000000 | 4680000 |
Friday, January 1, 2021 | 46385000000 | 4898000 |
Saturday, January 1, 2022 | 46159000000 | 155984000 |
Sunday, January 1, 2023 | 45006000000 | 496659000 |
Monday, January 1, 2024 | 48300000000 |
Infusing magic into the data realm
In the dynamic world of pharmaceuticals, Bristol-Myers Squibb Company and Telix Pharmaceuticals Limited have charted distinct paths over the past decade. Bristol-Myers Squibb, a titan in the industry, has seen its revenue grow by approximately 183% from 2014 to 2023, peaking in 2021. This growth underscores its robust market presence and strategic acquisitions. In contrast, Telix Pharmaceuticals, a rising star, has experienced an explosive growth of over 1,600% in the same period, reflecting its innovative approach and expanding product pipeline.
While Bristol-Myers Squibb's revenue surged significantly in 2020, Telix's revenue saw a remarkable jump in 2022, highlighting its breakthrough developments. This comparison not only showcases the diverse strategies of established and emerging players but also offers insights into the evolving landscape of the pharmaceutical industry.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Genmab A/S or Telix Pharmaceuticals Limited: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Walgreens Boots Alliance, Inc. vs Telix Pharmaceuticals Limited
Who Generates More Revenue? Telix Pharmaceuticals Limited or Ligand Pharmaceuticals Incorporated